Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial.
- DOI
- 10.1016/s1473-3099(16)30529-1
- Published
- 2017 Mar
- Container
- The Lancet. Infectious diseases
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1473-3099-16-30529-1,
title = {Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial.},
author = {Schwameis M and Kündig T and Huber G and von Bidder L and Meinel L and Weisser R and Aberer E and Härter G and Weinke T and Jelinek T and Fätkenheuer G and Wollina U and Burchard GD and Aschoff R and Nischik R and Sattler G and Popp G and Lotte W and Wiechert D and Eder G and Maus O and Staubach-Renz P and Gräfe A and Geigenberger V and Naudts I and Sebastian M and Reider N and Weber R and Heckmann M and Reisinger EC and Klein G and Wantzen J and Jilma B},
year = {2017},
journal = {The Lancet. Infectious diseases},
doi = {10.1016/s1473-3099(16)30529-1},
url = {https://doi.org/10.1016/s1473-3099(16)30529-1}
}RIS
TY - JOUR TI - Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial. AU - Schwameis M AU - Kündig T AU - Huber G AU - von Bidder L AU - Meinel L AU - Weisser R AU - Aberer E AU - Härter G AU - Weinke T AU - Jelinek T AU - Fätkenheuer G AU - Wollina U AU - Burchard GD AU - Aschoff R AU - Nischik R AU - Sattler G AU - Popp G AU - Lotte W AU - Wiechert D AU - Eder G AU - Maus O AU - Staubach-Renz P AU - Gräfe A AU - Geigenberger V AU - Naudts I AU - Sebastian M AU - Reider N AU - Weber R AU - Heckmann M AU - Reisinger EC AU - Klein G AU - Wantzen J AU - Jilma B PY - 2017 JO - The Lancet. Infectious diseases DO - 10.1016/s1473-3099(16)30529-1 UR - https://doi.org/10.1016/s1473-3099(16)30529-1 ER -
APA
M, S., T, K., G, H., L, V. B., L, M., R, W., E, A., G, H., T, W., T, J., G, F., U, W., GD, B., R, A., R, N., G, S., G, P., W, L., D, W., G, E., O, M., P, S., A, G., V, G., I, N., M, S., N, R., R, W., M, H., EC, R., G, K., J, W., & B, J. (2017). Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial.. The Lancet. Infectious diseases. https://doi.org/10.1016/s1473-3099(16)30529-1
Source records
- pubmed · retrieved 2026-09-26T21:04:38.558Z